Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Gene genie: can CRISPR-Cas9 deliver on its promise to transform genome therapy?
  2. James MacKenzie Q&A: How late-stage packaging customisation is shaking up the pharmaceutical supply chain
  3. Exscientia’s partnership spree continues with $25m Celgene deal
  4. Blue Brain Project clarifies neurons’ structure and role in disease
  5. False flags: are search engines benefiting rogue online pharmacies?

Latest Content

The Nymi™ Band

This white paper provides the reader with an overview of the Nymi Band™ and how it works. 

Gene genie: can CRISPR-Cas9 deliver on its promise to transform genome therapy?

Experimental treatments based on CRISPR-Cas9 gene editing technology are at a crossroads, with the first European trial now enrolling patients and new clinical applications and delivery methods steadily emerging. It’s not all good news though; two studies in 2018 found that a majority of patients had T-cell immunity against a type of Cas9. Sally Turner investigates at this important juncture.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top